Cetuximab-related tumor lysis syndrome in metastatic colon carcinoma

J Clin Oncol. 2008 May 10;26(14):2406-8. doi: 10.1200/JCO.2007.14.7603.

Authors

Ganapathy Krishnan¹, Karl D'Silva, Anas Al-Janadi

Affiliation

¹ Department of Internal Medicine, Division of Hematology and Oncology, Michigan State University, East Lansing, MI, USA.

PMID: 18467734
DOI: 10.1200/JCO.2007.14.7603

No abstract available

Publication types

Case Reports

MeSH terms

Adenocarcinoma / drug therapy*
Adenocarcinoma / secondary
Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal / therapeutic use
Antibodies, Monoclonal, Humanized
Antineoplastic Agents / adverse effects*
Antineoplastic Agents / therapeutic use
Cetuximab
Colonic Neoplasms / drug therapy*
Colonic Neoplasms / pathology
Humans
Liver Neoplasms / drug therapy*
Liver Neoplasms / secondary
Male
Middle Aged
Tumor Lysis Syndrome / etiology*

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Cetuximab

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.

Alternative Proxies:

Alternative Proxy